Cryoport, Inc.
CYRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124524
In the last 90 days, Cryoport, Inc. insiders filed 0 open-market purchases and 2 sales; 184 institutions reported holding it in 13F filings for Q2 2026, worth $707.5M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:40 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net income for FY2025: $78.3M (44.4% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 3, 2026 | Mar 4, 2025 | Mar 12, 2024 | Feb 23, 2023 | Feb 24, 2022 |
| Revenue | $176.2M | $228.4M | $233.3M | $237.3M | $222.6M |
| Cost of revenue | $93.1M | $128.8M | $133.9M | $133.4M | $126.0M |
| Gross profit | $83.1M | $99.6M | $99.3M | $103.9M | $96.6M |
| Operating expenses | $119.9M | $230.5M | $214.5M | $135.8M | $114.4M |
| Research and development | $17.0M | $17.7M | $18.0M | $15.7M | $16.8M |
| Selling, general and administrative | $102.8M | $149.0M | $146.9M | $120.1M | $97.6M |
| Operating income | -$36.8M | -$130.9M | -$115.2M | -$31.9M | -$17.8M |
| Interest expense | – | – | $5.50M | $6.14M | $4.69M |
| Income tax | $1.80M | $1.28M | $239.0K | $2.24M | $1.69M |
| Net income | $78.3M | -$114.8M | -$99.6M | -$37.3M | -$275.5M |
| EPS, basic | $1.40 | $-2.49 | $-2.21 | $-0.93 | $-6.18 |
| EPS, diluted | $1.40 | $-2.49 | $-2.21 | $-0.93 | $-6.19 |
| Weighted shares, basic | 50.1M | 49.3M | 48.7M | 49.0M | 45.9M |
| Weighted shares, diluted | 50.1M | 49.3M | 48.7M | 49.0M | 45.9M |
| Margins and growth | |||||
| Gross margin | 47.1% | 43.6% | 42.6% | 43.8% | 43.4% |
| Operating margin | -20.9% | -57.3% | -49.4% | -13.4% | -8.0% |
| Net margin | 44.4% | -50.2% | -42.7% | -15.7% | -123.8% |
| Revenue growth, year over year | −22.9% | −2.1% | −1.7% | +6.6% | +182.9% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 3, 2026 | Mar 4, 2025 | Mar 12, 2024 | Feb 23, 2023 | Feb 24, 2022 |
| Cash and equivalents | $250.5M | $45.3M | $46.3M | $36.6M | $139.1M |
| Short-term investments | $160.7M | $216.5M | $410.4M | $486.7M | $489.7M |
| Accounts receivable | $33.4M | $45.8M | $42.1M | $43.9M | $39.4M |
| Inventory | $23.2M | $22.5M | $26.2M | $27.7M | $16.5M |
| Total current assets | $476.2M | $341.6M | $535.1M | $604.2M | $693.5M |
| Property, plant and equipment | $85.4M | $88.8M | $84.9M | $63.6M | $49.0M |
| Goodwill | $22.4M | $51.7M | $108.4M | $151.1M | $147.0M |
| Intangible assets | $138.1M | $170.5M | $194.4M | $191.0M | $201.4M |
| Total assets | $765.0M | $703.5M | $957.7M | $1.04B | $1.11B |
| Total current liabilities | $219.0M | $64.6M | $45.6M | $40.9M | $42.6M |
| Total liabilities | $262.4M | $301.6M | $468.7M | $482.9M | $471.1M |
| Shareholders' equity | $502.6M | $401.9M | $489.0M | $555.8M | $641.8M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 3, 2026 | Mar 4, 2025 | Mar 12, 2024 | Feb 23, 2023 | Feb 24, 2022 |
| Operating cash flow | -$8.58M | -$16.3M | -$757.0K | -$1.85M | $8.13M |
| Capital expenditures | $16.4M | $17.3M | $38.8M | $22.1M | $23.9M |
| Free cash flow | -$25.0M | -$33.6M | -$39.5M | -$24.0M | -$15.8M |
| Depreciation and amortization | $27.7M | $30.8M | $27.5M | $22.8M | $20.2M |
| Stock-based compensation | $10.1M | $19.7M | $22.8M | $20.1M | $15.3M |
| Share buybacks | $10.0M | – | – | $38.0M | – |
| Investing cash flow | $250.3M | $176.8M | $36.0M | -$59.7M | -$469.3M |
| Financing cash flow | -$21.1M | -$161.5M | -$23.8M | -$39.2M | $564.3M |
| Net change in cash | $205.2M | -$1.06M | $9.75M | -$102.5M | $102.2M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 5.7% | 8.6% | 9.8% | 8.5% | 6.9% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 30, 2026 | 50.7M | +1.3% | SEC |
| Jul 31, 2026 | 50.6M | +1.2% | SEC |
| Apr 28, 2026 | 50.4M | +0.5% | SEC |
| Feb 27, 2026 | 49.9M | −0.1% | SEC |
| Oct 31, 2025 | 50.1M | +1.3% | SEC |
| Aug 8, 2025 | 50.1M | +1.3% | SEC |
| Apr 25, 2025 | 50.1M | +1.8% | SEC |
| Feb 28, 2025 | 49.9M | +1.9% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.